Clinical drug interaction studies with either formulation
No evidence found.
Effect of VK2735 on gastric emptying and absorption of oral medications
No evidence found.
Class context: tirzepatide (Zepbound) with insulin or an insulin secretagogue
Class context: tirzepatide (Zepbound) with oral medications and oral hormonal contraceptives
Class context: tirzepatide (Zepbound) effects on CYP enzymes, transporters, and oral contraceptive exposure
“In vitro studies have shown low potential for tirzepatide to inhibit or induce CYP enzymes, and to inhibit drug transporters.” (opens the source at this quote in a new tab)
“Following administration of a combined oral contraceptive (0.035 mg ethinyl estradiol and 0.25 mg norgestimate) in the presence of a single dose of tirzepatide 5 mg, mean C max of ethinyl estradiol, norgestimate, and norelgestromin was reduced by 59%, 66%, and 55%, while mean AUC was reduced by 20%, 21%, and 23%, respectively.” (opens the source at this quote in a new tab)